APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bovine Medicine and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bovine Medicine and Vaccines Market Analysis and Forecast 2026-2032

2 January 2026203 pages

Choose your research edition.

Industry ResearchBovine Medicine and Vaccines Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Bovine Medicine and Vaccines Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Bovine Medicine and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bovine Medicine and Vaccines Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Bovine Medicine and Vaccines Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Bovine Medicine and Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Bovine Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bovine Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bovine Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bovine Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Bovine Medicine and Vaccines include Agrovet, Bayer HealthCare, BIGVET Biotech, Biogenesis Bagó, Boehringer Ingelheim, Brilliant Bio Pharma, BVI, CAHIC and Cavet Bio, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Bovine Medicine and Vaccines, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bovine Medicine and Vaccines, also provides the revenue of main regions and countries. Of the upcoming market potential for Bovine Medicine and Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bovine Medicine and Vaccines revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bovine Medicine and Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Bovine Medicine and Vaccines revenue, projected growth trends, production technology, application and end-user industry.

Bovine Medicine and Vaccines Segment by Company

Agrovet

Bayer HealthCare

BIGVET Biotech

Biogenesis Bagó

Boehringer Ingelheim

Brilliant Bio Pharma

BVI

CAHIC

Cavet Bio

CEVA

Indian Immunologicals

LIMOR

ME VAC

MSD Animal Health

Sanofi (Merial)

Shen Lian

Tecon Group

VECOL

VETAL

Jinyu Group

Bovine Medicine and Vaccines Segment by Type

Medicine

Vaccines

Bovine Medicine and Vaccines Segment by Application

Farm

Government

Bovine Medicine and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bovine Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bovine Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bovine Medicine and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Bovine Medicine and Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Bovine Medicine and Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bovine Medicine and Vaccines revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bovine Medicine and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Medicine Major Player Table 3. Vaccines Major Player Table 4. Global Bovine Medicine and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Farm Major Player Table 6. Government Major Player Table 7. Bovine Medicine and Vaccines Industry Trends Table 8. Bovine Medicine and Vaccines Industry Drivers Table 9. Bovine Medicine and Vaccines Industry Opportunities and Challenges Table 10. Bovine Medicine and Vaccines Industry Restraints Table 11. Global Bovine Medicine and Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Bovine Medicine and Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Bovine Medicine and Vaccines Market Share by Region (2021-2026) Table 14. Global Bovine Medicine and Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Bovine Medicine and Vaccines Market Share by Region (2027-2032) Table 16. Global Bovine Medicine and Vaccines Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Bovine Medicine and Vaccines Revenue Market Share by Players (2021-2026) Table 18. Global Bovine Medicine and Vaccines Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Bovine Medicine and Vaccines Key Players Headquarters & Area Served Table 20. Global Bovine Medicine and Vaccines Players, Product Type & Application Table 21. Global Bovine Medicine and Vaccines Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Bovine Medicine and Vaccines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Bovine Medicine and Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bovine Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Bovine Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Bovine Medicine and Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global Bovine Medicine and Vaccines Revenue Market Share by Type (2027-2032) Table 29. Global Bovine Medicine and Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Bovine Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Bovine Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Bovine Medicine and Vaccines Revenue Market Share by Application (2021-2026) Table 33. Global Bovine Medicine and Vaccines Revenue Market Share by Application (2027-2032) Table 34. Agrovet Company Information Table 35. Agrovet Business Overview Table 36. Agrovet Bovine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Agrovet Bovine Medicine and Vaccines Product Portfolio Table 38. Agrovet Recent Development Table 39. Bayer HealthCare Company Information Table 40. Bayer HealthCare Business Overview Table 41. Bayer HealthCare Bovine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Bayer HealthCare Bovine Medicine and Vaccines Product Portfolio Table 43. Bayer HealthCare Recent Development Table 44. BIGVET Biotech Company Information Table 45. BIGVET Biotech Business Overview Table 46. BIGVET Biotech Bovine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. BIGVET Biotech Bovine Medicine and Vaccines Product Portfolio Table 48. BIGVET Biotech Recent Development Table 49. Biogenesis Bagó Company Information Table 50. Biogenesis Bagó Business Overview Table 51. Biogenesis Bagó Bovine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Biogenesis Bagó Bovine Medicine and Vaccines Product Portfolio Table 53. Biogenesis Bagó Recent Development Table 54. Boehringer Ingelheim Company Information Table 55. Boehringer Ingelheim Business Overview Table 56. Boehringer Ingelheim Bovine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Boehringer Ingelheim Bovine Medicine and Vaccines Product Portfolio Table 58. Boehringer Ingelheim Recent Development Table 59. Brilliant Bio Pharma Company Information Table 60. Brilliant Bio Pharma Business Overview Table 61. Brilliant Bio Pharma Bovine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Brilliant Bio Pharma Bovine Medicine and Vaccines Product Portfolio Table 63. Brilliant Bio Pharma Recent Development Table 64. BVI Company Information Table 65. BVI Business Overview Table 66. BVI Bovine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. BVI Bovine Medicine and Vaccines Product Portfolio Table 68. BVI Recent Development Table 69. CAHIC Company Information Table 70. CAHIC Business Overview Table 71. CAHIC Bovine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. CAHIC Bovine Medicine and Vaccines Product Portfolio Table 73. CAHIC Recent Development Table 74. Cavet Bio Company Information Table 75. Cavet Bio Business Overview Table 76. Cavet Bio Bovine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Cavet Bio Bovine Medicine and Vaccines Product Portfolio Table 78. Cavet Bio Recent Development Table 79. CEVA Company Information Table 80. CEVA Business Overview Table 81. CEVA Bovine Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. CEVA Bovine Medicine and Vaccines Product Portfolio Table 83. CEVA Recent Development Table 84. Indian Immunologicals Company Information Table 85. Indian Immunologicals Business Overview Table 86. Indian Immunologicals Bovine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Indian Immunologicals Bovine Medicine and Vaccines Product Portfolio Table 88. Indian Immunologicals Recent Development Table 89. LIMOR Company Information Table 90. LIMOR Business Overview Table 91. LIMOR Bovine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. LIMOR Bovine Medicine and Vaccines Product Portfolio Table 93. LIMOR Recent Development Table 94. ME VAC Company Information Table 95. ME VAC Business Overview Table 96. ME VAC Bovine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. ME VAC Bovine Medicine and Vaccines Product Portfolio Table 98. ME VAC Recent Development Table 99. MSD Animal Health Company Information Table 100. MSD Animal Health Business Overview Table 101. MSD Animal Health Bovine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. MSD Animal Health Bovine Medicine and Vaccines Product Portfolio Table 103. MSD Animal Health Recent Development Table 104. Sanofi (Merial) Company Information Table 105. Sanofi (Merial) Business Overview Table 106. Sanofi (Merial) Bovine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Sanofi (Merial) Bovine Medicine and Vaccines Product Portfolio Table 108. Sanofi (Merial) Recent Development Table 109. Shen Lian Company Information Table 110. Shen Lian Business Overview Table 111. Shen Lian Bovine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Shen Lian Bovine Medicine and Vaccines Product Portfolio Table 113. Shen Lian Recent Development Table 114. Tecon Group Company Information Table 115. Tecon Group Business Overview Table 116. Tecon Group Bovine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Tecon Group Bovine Medicine and Vaccines Product Portfolio Table 118. Tecon Group Recent Development Table 119. VECOL Company Information Table 120. VECOL Business Overview Table 121. VECOL Bovine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. VECOL Bovine Medicine and Vaccines Product Portfolio Table 123. VECOL Recent Development Table 124. VETAL Company Information Table 125. VETAL Business Overview Table 126. VETAL Bovine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. VETAL Bovine Medicine and Vaccines Product Portfolio Table 128. VETAL Recent Development Table 129. Jinyu Group Company Information Table 130. Jinyu Group Business Overview Table 131. Jinyu Group Bovine Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Jinyu Group Bovine Medicine and Vaccines Product Portfolio Table 133. Jinyu Group Recent Development Table 134. North America Bovine Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 135. North America Bovine Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 136. North America Bovine Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 137. North America Bovine Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 138. North America Bovine Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. North America Bovine Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 140. North America Bovine Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 141. Europe Bovine Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 142. Europe Bovine Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 143. Europe Bovine Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 144. Europe Bovine Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 145. Europe Bovine Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Europe Bovine Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 147. Europe Bovine Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 148. China Bovine Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 149. China Bovine Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 150. China Bovine Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 151. China Bovine Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Bovine Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Bovine Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Bovine Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 155. Asia Bovine Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 156. Asia Bovine Medicine and Vaccines Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Asia Bovine Medicine and Vaccines Revenue by Region (US$ Million) & (2021-2026) Table 158. Asia Bovine Medicine and Vaccines Revenue by Region (US$ Million) & (2027-2032) Table 159. SAMEA Bovine Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 160. SAMEA Bovine Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 161. SAMEA Bovine Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 162. SAMEA Bovine Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 163. SAMEA Bovine Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. SAMEA Bovine Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 165. SAMEA Bovine Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Bovine Medicine and Vaccines Image Figure 2. Global Bovine Medicine and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bovine Medicine and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Medicine Image Figure 5. Vaccines Image Figure 6. Global Bovine Medicine and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Bovine Medicine and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Farm Image Figure 9. Government Image Figure 10. Global Bovine Medicine and Vaccines Market Size (US$ Million) & (2021-2032) Figure 11. Global Bovine Medicine and Vaccines Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Bovine Medicine and Vaccines Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Bovine Medicine and Vaccines Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Bovine Medicine and Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Bovine Medicine and Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Bovine Medicine and Vaccines Revenue Market Share by Type (2021-2032) Figure 18. Global Bovine Medicine and Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Bovine Medicine and Vaccines Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Bovine Medicine and Vaccines Revenue Market Share by Application (2021-2032) Figure 21. North America Bovine Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Bovine Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 23. North America Bovine Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 24. North America Bovine Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 25. United States Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Bovine Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Bovine Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 30. Europe Bovine Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 31. Europe Bovine Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 32. Germany Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Bovine Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Bovine Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 42. China Bovine Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 43. Asia Bovine Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Bovine Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 45. Asia Bovine Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 46. Asia Bovine Medicine and Vaccines Revenue Share by Region (2021-2032) Figure 47. Japan Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Bovine Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Bovine Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 55. SAMEA Bovine Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 56. SAMEA Bovine Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 57. Brazil Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Bovine Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Medicine
  • Vaccines
Applications
  • Farm
  • Government
Companies covered
  • Agrovet
  • Bayer HealthCare
  • BIGVET Biotech
  • Biogenesis Bagó
  • Boehringer Ingelheim
  • Brilliant Bio Pharma
  • BVI
  • CAHIC
  • Cavet Bio
  • CEVA
  • Indian Immunologicals
  • LIMOR
  • ME VAC
  • MSD Animal Health
  • Sanofi (Merial)
  • Shen Lian
  • Tecon Group
  • VECOL
  • VETAL
  • Jinyu Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bovine Medicine and Vaccines Market by Type
  3. 1.2.1 Global Bovine Medicine and Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Medicine
  5. 1.2.3 Vaccines
  6. 1.3 Bovine Medicine and Vaccines Market by Application
  7. 1.3.1 Global Bovine Medicine and Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Farm
  9. 1.3.3 Government
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Bovine Medicine and Vaccines Market Dynamics
  1. 2.1 Bovine Medicine and Vaccines Industry Trends
  2. 2.2 Bovine Medicine and Vaccines Industry Drivers
  3. 2.3 Bovine Medicine and Vaccines Industry Opportunities and Challenges
  4. 2.4 Bovine Medicine and Vaccines Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Bovine Medicine and Vaccines Market Perspective (2021-2032)
  2. 3.2 Global Bovine Medicine and Vaccines Growth Trends by Region
  3. 3.2.1 Global Bovine Medicine and Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bovine Medicine and Vaccines Market Size by Region (2021-2026)
  5. 3.2.3 Global Bovine Medicine and Vaccines Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Bovine Medicine and Vaccines Revenue by Players
  2. 4.1.1 Global Bovine Medicine and Vaccines Revenue by Players (2021-2026)
  3. 4.1.2 Global Bovine Medicine and Vaccines Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Bovine Medicine and Vaccines Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bovine Medicine and Vaccines Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Bovine Medicine and Vaccines Key Players Headquarters & Area Served
  7. 4.4 Global Bovine Medicine and Vaccines Players, Product Type & Application
  8. 4.5 Global Bovine Medicine and Vaccines Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Bovine Medicine and Vaccines Market CR5 and HHI
  11. 4.6.3 2025 Bovine Medicine and Vaccines Tier 1, Tier 2, and Tier 3
5 Bovine Medicine and Vaccines Market Size by Type
  1. 5.1 Global Bovine Medicine and Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Bovine Medicine and Vaccines Revenue by Type (2021-2032)
  3. 5.3 Global Bovine Medicine and Vaccines Revenue Market Share by Type (2021-2032)
6 Bovine Medicine and Vaccines Market Size by Application
  1. 6.1 Global Bovine Medicine and Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Bovine Medicine and Vaccines Revenue by Application (2021-2032)
  3. 6.3 Global Bovine Medicine and Vaccines Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Agrovet
  2. 7.1.1 Agrovet Company Information
  3. 7.1.2 Agrovet Business Overview
  4. 7.1.3 Agrovet Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Agrovet Bovine Medicine and Vaccines Product Portfolio
  6. 7.1.5 Agrovet Recent Developments
  7. 7.2 Bayer HealthCare
  8. 7.2.1 Bayer HealthCare Company Information
  9. 7.2.2 Bayer HealthCare Business Overview
  10. 7.2.3 Bayer HealthCare Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bayer HealthCare Bovine Medicine and Vaccines Product Portfolio
  12. 7.2.5 Bayer HealthCare Recent Developments
  13. 7.3 BIGVET Biotech
  14. 7.3.1 BIGVET Biotech Company Information
  15. 7.3.2 BIGVET Biotech Business Overview
  16. 7.3.3 BIGVET Biotech Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BIGVET Biotech Bovine Medicine and Vaccines Product Portfolio
  18. 7.3.5 BIGVET Biotech Recent Developments
  19. 7.4 Biogenesis Bagó
  20. 7.4.1 Biogenesis Bagó Company Information
  21. 7.4.2 Biogenesis Bagó Business Overview
  22. 7.4.3 Biogenesis Bagó Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Biogenesis Bagó Bovine Medicine and Vaccines Product Portfolio
  24. 7.4.5 Biogenesis Bagó Recent Developments
  25. 7.5 Boehringer Ingelheim
  26. 7.5.1 Boehringer Ingelheim Company Information
  27. 7.5.2 Boehringer Ingelheim Business Overview
  28. 7.5.3 Boehringer Ingelheim Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Boehringer Ingelheim Bovine Medicine and Vaccines Product Portfolio
  30. 7.5.5 Boehringer Ingelheim Recent Developments
  31. 7.6 Brilliant Bio Pharma
  32. 7.6.1 Brilliant Bio Pharma Company Information
  33. 7.6.2 Brilliant Bio Pharma Business Overview
  34. 7.6.3 Brilliant Bio Pharma Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Brilliant Bio Pharma Bovine Medicine and Vaccines Product Portfolio
  36. 7.6.5 Brilliant Bio Pharma Recent Developments
  37. 7.7 BVI
  38. 7.7.1 BVI Company Information
  39. 7.7.2 BVI Business Overview
  40. 7.7.3 BVI Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  41. 7.7.4 BVI Bovine Medicine and Vaccines Product Portfolio
  42. 7.7.5 BVI Recent Developments
  43. 7.8 CAHIC
  44. 7.8.1 CAHIC Company Information
  45. 7.8.2 CAHIC Business Overview
  46. 7.8.3 CAHIC Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  47. 7.8.4 CAHIC Bovine Medicine and Vaccines Product Portfolio
  48. 7.8.5 CAHIC Recent Developments
  49. 7.9 Cavet Bio
  50. 7.9.1 Cavet Bio Company Information
  51. 7.9.2 Cavet Bio Business Overview
  52. 7.9.3 Cavet Bio Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Cavet Bio Bovine Medicine and Vaccines Product Portfolio
  54. 7.9.5 Cavet Bio Recent Developments
  55. 7.10 CEVA
  56. 7.10.1 CEVA Company Information
  57. 7.10.2 CEVA Business Overview
  58. 7.10.3 CEVA Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  59. 7.10.4 CEVA Bovine Medicine and Vaccines Product Portfolio
  60. 7.10.5 CEVA Recent Developments
  61. 7.11 Indian Immunologicals
  62. 7.11.1 Indian Immunologicals Company Information
  63. 7.11.2 Indian Immunologicals Business Overview
  64. 7.11.3 Indian Immunologicals Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Indian Immunologicals Bovine Medicine and Vaccines Product Portfolio
  66. 7.11.5 Indian Immunologicals Recent Developments
  67. 7.12 LIMOR
  68. 7.12.1 LIMOR Company Information
  69. 7.12.2 LIMOR Business Overview
  70. 7.12.3 LIMOR Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  71. 7.12.4 LIMOR Bovine Medicine and Vaccines Product Portfolio
  72. 7.12.5 LIMOR Recent Developments
  73. 7.13 ME VAC
  74. 7.13.1 ME VAC Company Information
  75. 7.13.2 ME VAC Business Overview
  76. 7.13.3 ME VAC Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  77. 7.13.4 ME VAC Bovine Medicine and Vaccines Product Portfolio
  78. 7.13.5 ME VAC Recent Developments
  79. 7.14 MSD Animal Health
  80. 7.14.1 MSD Animal Health Company Information
  81. 7.14.2 MSD Animal Health Business Overview
  82. 7.14.3 MSD Animal Health Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  83. 7.14.4 MSD Animal Health Bovine Medicine and Vaccines Product Portfolio
  84. 7.14.5 MSD Animal Health Recent Developments
  85. 7.15 Sanofi (Merial)
  86. 7.15.1 Sanofi (Merial) Company Information
  87. 7.15.2 Sanofi (Merial) Business Overview
  88. 7.15.3 Sanofi (Merial) Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Sanofi (Merial) Bovine Medicine and Vaccines Product Portfolio
  90. 7.15.5 Sanofi (Merial) Recent Developments
  91. 7.16 Shen Lian
  92. 7.16.1 Shen Lian Company Information
  93. 7.16.2 Shen Lian Business Overview
  94. 7.16.3 Shen Lian Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Shen Lian Bovine Medicine and Vaccines Product Portfolio
  96. 7.16.5 Shen Lian Recent Developments
  97. 7.17 Tecon Group
  98. 7.17.1 Tecon Group Company Information
  99. 7.17.2 Tecon Group Business Overview
  100. 7.17.3 Tecon Group Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Tecon Group Bovine Medicine and Vaccines Product Portfolio
  102. 7.17.5 Tecon Group Recent Developments
  103. 7.18 VECOL
  104. 7.18.1 VECOL Company Information
  105. 7.18.2 VECOL Business Overview
  106. 7.18.3 VECOL Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  107. 7.18.4 VECOL Bovine Medicine and Vaccines Product Portfolio
  108. 7.18.5 VECOL Recent Developments
  109. 7.19 VETAL
  110. 7.19.1 VETAL Company Information
  111. 7.19.2 VETAL Business Overview
  112. 7.19.3 VETAL Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  113. 7.19.4 VETAL Bovine Medicine and Vaccines Product Portfolio
  114. 7.19.5 VETAL Recent Developments
  115. 7.20 Jinyu Group
  116. 7.20.1 Jinyu Group Company Information
  117. 7.20.2 Jinyu Group Business Overview
  118. 7.20.3 Jinyu Group Bovine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Jinyu Group Bovine Medicine and Vaccines Product Portfolio
  120. 7.20.5 Jinyu Group Recent Developments
8 North America
  1. 8.1 North America Bovine Medicine and Vaccines Revenue (2021-2032)
  2. 8.2 North America Bovine Medicine and Vaccines Revenue by Type (2021-2032)
  3. 8.2.1 North America Bovine Medicine and Vaccines Revenue by Type (2021-2026)
  4. 8.2.2 North America Bovine Medicine and Vaccines Revenue by Type (2027-2032)
  5. 8.3 North America Bovine Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 8.4 North America Bovine Medicine and Vaccines Revenue by Application (2021-2032)
  7. 8.4.1 North America Bovine Medicine and Vaccines Revenue by Application (2021-2026)
  8. 8.4.2 North America Bovine Medicine and Vaccines Revenue by Application (2027-2032)
  9. 8.5 North America Bovine Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 8.6 North America Bovine Medicine and Vaccines Revenue by Country
  11. 8.6.1 North America Bovine Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Bovine Medicine and Vaccines Revenue by Country (2021-2026)
  13. 8.6.3 North America Bovine Medicine and Vaccines Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Bovine Medicine and Vaccines Revenue (2021-2032)
  2. 9.2 Europe Bovine Medicine and Vaccines Revenue by Type (2021-2032)
  3. 9.2.1 Europe Bovine Medicine and Vaccines Revenue by Type (2021-2026)
  4. 9.2.2 Europe Bovine Medicine and Vaccines Revenue by Type (2027-2032)
  5. 9.3 Europe Bovine Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 9.4 Europe Bovine Medicine and Vaccines Revenue by Application (2021-2032)
  7. 9.4.1 Europe Bovine Medicine and Vaccines Revenue by Application (2021-2026)
  8. 9.4.2 Europe Bovine Medicine and Vaccines Revenue by Application (2027-2032)
  9. 9.5 Europe Bovine Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 9.6 Europe Bovine Medicine and Vaccines Revenue by Country
  11. 9.6.1 Europe Bovine Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Bovine Medicine and Vaccines Revenue by Country (2021-2026)
  13. 9.6.3 Europe Bovine Medicine and Vaccines Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Bovine Medicine and Vaccines Revenue (2021-2032)
  2. 10.2 China Bovine Medicine and Vaccines Revenue by Type (2021-2032)
  3. 10.2.1 China Bovine Medicine and Vaccines Revenue by Type (2021-2026)
  4. 10.2.2 China Bovine Medicine and Vaccines Revenue by Type (2027-2032)
  5. 10.3 China Bovine Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 10.4 China Bovine Medicine and Vaccines Revenue by Application (2021-2032)
  7. 10.4.1 China Bovine Medicine and Vaccines Revenue by Application (2021-2026)
  8. 10.4.2 China Bovine Medicine and Vaccines Revenue by Application (2027-2032)
  9. 10.5 China Bovine Medicine and Vaccines Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bovine Medicine and Vaccines Revenue (2021-2032)
  2. 11.2 Asia Bovine Medicine and Vaccines Revenue by Type (2021-2032)
  3. 11.2.1 Asia Bovine Medicine and Vaccines Revenue by Type (2021-2026)
  4. 11.2.2 Asia Bovine Medicine and Vaccines Revenue by Type (2027-2032)
  5. 11.3 Asia Bovine Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 11.4 Asia Bovine Medicine and Vaccines Revenue by Application (2021-2032)
  7. 11.4.1 Asia Bovine Medicine and Vaccines Revenue by Application (2021-2026)
  8. 11.4.2 Asia Bovine Medicine and Vaccines Revenue by Application (2027-2032)
  9. 11.5 Asia Bovine Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 11.6 Asia Bovine Medicine and Vaccines Revenue by Country
  11. 11.6.1 Asia Bovine Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Bovine Medicine and Vaccines Revenue by Country (2021-2026)
  13. 11.6.3 Asia Bovine Medicine and Vaccines Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bovine Medicine and Vaccines Revenue (2021-2032)
  2. 12.2 SAMEA Bovine Medicine and Vaccines Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Bovine Medicine and Vaccines Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Bovine Medicine and Vaccines Revenue by Type (2027-2032)
  5. 12.3 SAMEA Bovine Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Bovine Medicine and Vaccines Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Bovine Medicine and Vaccines Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Bovine Medicine and Vaccines Revenue by Application (2027-2032)
  9. 12.5 SAMEA Bovine Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Bovine Medicine and Vaccines Revenue by Country
  11. 12.6.1 SAMEA Bovine Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Bovine Medicine and Vaccines Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Bovine Medicine and Vaccines Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst